Osteoporosis Clinical Trial
— PMO-WBV-sEMGOfficial title:
Effect of Hip Bone Mineral Density / Content on Vibration-Induced Hip Adductors Muscle Electrical Activity in Postmenopausal Women
| Verified date | January 2013 |
| Source | Bagcilar Training and Research Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Turkey: Ministry of Health |
| Study type | Interventional |
The aim of this study is to investigate effects of femur exposed to vibration on the rest
muscle electrical activity of hip adductors in cases with postmenopausal osteoporosis.
Among patients who will be admitted to the investigators clinic for out-patients and whose
bone densitometric measurement will be made with a prediagnosis postmenopausal osteoporosis,
a total of 80 voluntaries [40 having postmenopausal osteoporosis (femur neck or total hip T
score < -2.0) and 40 Controls (Hip and lumbar bone mineral density normal)] are planned to
include in this study.
After the left hip bone mineral density (BMD) and BMC is measured in all cases, whole body
vibration will be applied in PMO groups and Controls. The rest muscle electrical activity of
left hip muscles will be evaluated at pre-treatment, post-treatment and, during treatment in
patients with PMO and then their data will be compared with Controls data.
Plasma sclerostin level will be measured before and 10th minute after vibration.
Cases will stand on vibration plate. WBV will be applied at a frequency of 40 Hz and
amplitude of 2 mm for 30 + 30 seconds. WBV will be applied one session only. The left hip
BMD and BMC will be evaluated by bone densitometer (Norland).
The rest muscle electrical activity of hip adductor muscles at rest will be measured by
PowerLab (data acquisition system, ADInstruments, Australia) device.
This project is planed to be completed in 3 months.
| Status | Completed |
| Enrollment | 80 |
| Est. completion date | July 2011 |
| Est. primary completion date | June 2011 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 45 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - postmenopausal women with osteoporosis(femur neck or total hip T score<-2) or postmenopausal women without osteoporosis (normal femur and lumbar bone mineral density) - women with ages varying between 45 and 65 years - right handed women Exclusion Criteria: - secondary osteoporosis, fracture history - early menopause - osteopenia (-2 < femur neck or total hip T score < 1) - neuropathy (central or peripheral) - muscle, tendon, joint, vascular, dermatologic disease in lower extremity - postural abnormality (scoliosis, kyphosis,short leg etc) - systemic diseases (severe hypertension, coronary heart disease, etc) - endocrine-metabolic bone diseases[paget, osteomalacia] - medication that could affect the musculoskeletal system - obesity (BMI >30 kg/m2 or body weight>80kg) - professional sportswoman - female doing regular sports activities - non-cooperative subject - vertigo |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Bagcilar Training & Research Hospital | Istanbul |
| Lead Sponsor | Collaborator |
|---|---|
| Bagcilar Training and Research Hospital | Istanbul University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Vibration-induced muscle electrical activity | 3 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
| Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
| Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
| Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
| Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
| Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
| Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
| Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
| Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
| Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
| Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
| Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
| Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
| Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
| Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
| Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
| Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
| Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
| Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A | |
| Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A |